Cell-free systems to produce Virus-Like Particles !

Mythbusting#1: Cell-free systems are only relevant for membrane proteins

Cell-free expressed OprF proteoliposomes as effective vaccine against Pseudomonas aeruginosa ?

The S-protein receptor binding domain (RBD): potential uses for SARS-CoV-2 immunization and detection

Proteoliposomes - ideal model systems for membrane protein analysis

The nucleocapsid protein of SARS-CoV-2: potential target for a vaccine

Can we use cell-free biotechnology to fight COVID-19 ?

Five reasons to label your proteins for NMR studies using cell-free systems.

Which extract is best for cell-free protein expression: wheat germ or E. coli?

Mythbusting #10 : “Cell-free systems are only relevant for protein synthesis"

Mythbusting #9 : “Cell-free systems do not produce functional protein complexes"

Mythbusting #8 : “Cell-free systems are complex; hence the increased uptake in recent years of cell-free kits.”

Mythbusting #7 : “Cell-free systems only work with plasmids”

Cell-free protein synthesis systems: the best chance for your project to succeed !

Mythbusting #6 : “Cell-free systems are not compatible with Good Manufacturing Practices (GMP grade).”

Mythbusting #5 : “Cell-free systems deliver low expression yields.”

Mythbusting #4 : “Cell-free systems only use bacterial extract.”

Mythbusting #3 : "Cell-free systems are not suitable for large-scale industrial applications"

Mythbusting #2: "Cell-free systems are slower than an E.coli cell-based system"

Mythbusting #1: "Cell-free systems are only relevant for membrane proteins"

Synthelis will attend the 3rd edition of the “Colloque POLEPHARMA Bioproduction”

Validation of a new method to characterize proteoliposome in solution by Force Spectroscopy with Atomic Force Microscopy

Applications for membrane proteins

Environment and definition of our activity

Synthelis : Our services

Topics

See all

Latest articles

Subscribe to our blog